TerminatedNCT01928446
Lithium for Suicide prevention in Mood Disorders
Medication studyUnited States
Understand this study
What will I do during this study?
Depending on the group, the protocol specifies the study medication (lithium) or a placebo (an inactive comparison treatment).
- Listed locations
- Phoenix and 27 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 8, 2015
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 519
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT01928446
- Official title
Show the full official title
CSP #590 - Lithium for Suicidal Behavior in Mood Disorders
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Phoenix · Tucson · North Little Rock
25 more locations
- Loma Linda
- Palo Alto
- San Diego
- Denver
- Miami
- Orlando
- Decatur
- Hines
- Indianapolis
- Boston
- Minneapolis
- Las Vegas
- Reno
- Asheville
- Cleveland
- Portland
- Philadelphia
- Pittsburgh
- Dallas
- Houston
- Temple
- Salt Lake City
- Seattle
- Madison
- Milwaukee
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including lithium and Placebo.
Is this study still recruiting?
The registry lists this study as terminated.
